GTP/ggS-Induced phosphorylation of myosin light chain kinase in smooth muscle  by Tang, Da-Chun et al.
Volume 331, number 3,272-275 FEBS 13051 
0 1993 Federation of European Biochemical Societies 00145793/93/$6.00 
October 1993 
GTPyS-Induced phosphorylation of myosin light chain kinase 
in smooth muscle 
Da-Chun Tang”, Yasutaka Kubotab, Kristine E. Kamma, James T. Stull*,* 
‘Department of Physiology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, 
TX 75235-9040, USA 
bFaculty of Dentistry, Second Department of Oral Surgery, Kyushu University, Fukuoka, 812, Japan 
Received 19 July 1993; revised version received 16 August 1993 
Phosphorylation of myosin light chain kinase by a Ca’+-dependent protein kinase increases the concentration of Ca2+/calmoduIin required for 
half-maximal activation. The Cal’ concentrations required for myosin light chain kinase phosphorylation in permeable smooth muscle are similar 
to those required for myosin light chain phosphorylation. Both GTPyS and carbachol increase the Ca*’ sensitivity of myosin light chain kinase 
phosphorylation as well as light chain phosphorylation. It is proposed that a similar G-protein mediated mechanism regulates the Ca*+-dependent 
phosphorylation of these two contractile proteins in smooth muscle. 
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1. INTRODUCTION activation by Ca2+, which provides a cellular mecha- 
nism for down regulating the Ca2+ signal. 
Phosphorylation of the regulatory light chain of 
smooth muscle myosin by Ca’+/calmodulin-dependent 
myosin light chain kinase increases actin-activated 
MgATPase activity and initiates smooth muscle con- 
traction [1,2]. Although the increase in [Ca2+li is a pri- 
mary determinant for myosin light chain phosphoryla- 
tion, this system may not be the only cellular process 
regulating smooth muscle contraction [3,4]. 
Myosin light chain kinase itself is phosphorylated to 
a high extent at a regulatory site (site A) near the cal- 
modulin-binding domain in smooth muscle stimulated 
to contract [5,6]. Phosphorylation of this site increases 
K CaM, the concentration of Ca”/calmodulin required 
for half-maximal activity [5,7]. Furthermore, myosin 
light chain kinase phosphorylation is Ca2+-dependent 
[5--Q and inhibited by KN-62, an inhibitor of the multi- 
functional calmodulin-dependent protein kinase II [7]. 
Thus, it is proposed that phosphorylation of myosin 
light chain kinase by Ca2’/calmodulin-dependent pro- 
tein kinase II desensitizes myosin light chain kinase to 
Cell membrane receptors are coupled by G-proteins 
to multiple signal transduction pathways [9,10]. In per- 
meabilized smooth muscle, GTPyS acts to potentiate 
Ca2+-dependent force development [l 11. The GTPyS- 
induced potentiation of smooth muscle contraction is 
secondary to an increase in myosin light chain phospho- 
rylation at serine-19, the site phosphorylated by myosin 
light chain kinase [12]. It has been proposed that the 
GTP analogue increases Ca2+ sensitivity of myosin light 
chain phosphorylation through inhibition of myosin 
light chain phosphatase [ 11,121. It is not known whether 
phosphorylation of myosin light chain kinase is also 
affected by GTPyS or agonists in permeable smooth 
muscle. The objective of this study was to determine if 
a G-protein mediated mechanism might also be in- 
volved in regulating the Ca2’ sensitivity of myosin light 
chain kinase phosphorylation in smooth muscle. This 
possibility was examined in permeable tracheal smooth 
muscle treated with GTPyS with Ca2’ concentrations 
buffered by EGTA. Agonist stimulation was also exam- 
ined. 
*Corresponding author. 2. MATERIALS AND METHODS 
Abbeviutions: [Ca2’],, free intracellular Ca2’ concentration; KN-62, 
l-[N-O-Bis(5-isoquinolinesulfonyl)-N-methyl-~-tyrosyl]~-phenylpip- 
erazine; G-protein, guanine nucleotide-binding protein; PSS, physio- 
logical salt solution; PAGE, polyacrylamide gel electrophoresis; 
PMSF, phenylmethylsulfonyl fluoride; EDTA, ethylenediamine- 
tetraacetic acid; MOPS, 3-[N-morpholinolpropane-sulfonic acid; 
EGTA, ethyleneglycol-bis @aminoethylether)N,N,K,N-tetraacetic 
acid; ksM, concentration of Ca*+/calmodulin required for half-maxi- 
mal activation; PIPES, piperazine-N,N-bis[2-ethane-sulfonic acid]. 
2.1. Isometric force 
Bovine tracheas were obtained from a local abattoir (Dallas City 
Packing), and smooth muscle tissue was dissected into small strips 
(0.1 x 2 x 0.02 mm). Organ transport and tissue dissection conditions 
were performed in a salt solution (PSS) as described previously [5,6]. 
The strip was mounted on a force transducer in a small quartz cham- 
ber (10 ~1 capacity) filled with PSS which was gassed with 95% Od5% 
CO*. The chamber solution was perfused at 2-3 s intervals. After 
eliciting a maximal contraction with 10 PM carbachol, the tissue was 
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permeabilized with /?-es&r for 25 min at room temperature in a relax- 
ing solution [12,13]. The lightly skinned preparation demonstrated 3-4 
highly reproducible contractions without calmodulin being added to 
the perfusion solution. Furthermore, the Ca2’ dependence of light 
chain phosphorylation (Fig. 1) is similar to results reported with intact 
fibers or cells [14,6,7]. Thus, it is unlikely that there was a significant 
loss of essential contractile proteins including calmodulin from the 
skinned fiber with this experimental protocol. This solution also con- 
tained 1 ,uM leupeptin to minimize proteolysis and 10 PM ionomycin 
to deplete Ca2+ from the sarcoplasmic reticulum. After skinning, the 
tissue was perfused in relaxing solution for 5 min. 
2.2. Myosin light chain phosphorylation 
Phosphorylation of myosin light chain was measured in skinned 
tracheal tissue prepared as described for the force measurements. The 
strips were fixed in acetone containing 10% trichloroacetic acid and 
10 mM dithiothreitol that was precooled to -WC. The strips were 
warmed to room temperature in the same solution and washed three 
times with diethyl ether to remove residual trichloroacetic acid. The 
protein was dissolved in 8 M urea-sample buffer [6]. The extent of 
myosin light chain phosphorylation was measured by separation of 
nonphosphorylated and phosphorylated forms of the light chain by 
glyceroVPAGE followed by electrophoretic transfer of the protein to 
nitrocellulose paper. Quantitation of the relative amounts of each 
form by an immunoblot procedure was performed as previously de- 
scribed [6,14]. 
2.3. Myosin light chain kinase activity ratio 
Changes in the calmodulin activation properties of myosin light 
chain kinase associated with phosphorylation of site A were measured 
in skinned tracheal tissue prepared as described for the force measure- 
ments [5,6,15]. Quick-frozen tissues were homogenized at 0°C for 15 
s in 20 ~01s. (w/v) of buffer containing 50 mM MOPS, 0.1% Nonidet 
P-40, 100 mM sodium pyrophosphate, 100 mM NaF, 250 mM NaCl, 
1 mM dithiothreitol, 50 PM PMSF, 1 PM leupeptin at pH 8.6 and 
stored in liquid nitrogen until assay. After thawing to 0“C the homo- 
genates were diluted I-lo-fold with a buffer containing 50 mM &PO,, 
4 mM EDTA and 1 mM dithiothreitol at pH 7.0; 5 ,~l were added to 
20 ~1 of a reaction solution containing (final concentration): 50 mM 
MOPS at pH 7.0,lO mM magnesium acetate, 1 mM dithiothreitol, 50 
PM cardiac light chain, 400 nM calmodulin, [Y-‘~P]ATP (200-300 
cpm/pmol) and 4 mM EGTA with CaCl, added to give a free Ca” 
concentration of 1 or IOOpM. The reaction was incubated at 30°C for 
8 min, and the 32P incorporated into light chain was measured. 
When there is an increase in the concentration of calmodulin re- 
quired for half-maximal activity (J&&, the ratio of activity measured 
at 1 (v) to that 100 (I’,_) PM free Ca*+ decreases quantitatively. An 
increase in the GM value associated with kinase phosphorylation at 
the regulatory site decreases the fractional kinase activity at a limiting 
Ca2’ concentration (1 ,uM) under standardized assay conditions. The 
magnitude of the change in GM after myosin light chain kinase 
phosphorvlation can be derived from the followina relationshin: 
i(Vi/v)‘-- l}/{(V,Jv) - 1) = k&M’/Ko+,, where the values of the 
ratios (v/V,,) and (v/I’,& are obtained before and after phosphoryl- 
ation, respectively, and &’ is the value of &,,, after phosphoryla- 
tion. It should be noted that the relationship between the decrease in 
the activity ratio and the increase in &+, is not linear [5,6,15]. 
2.4. Miscellaneous 
The composition of PSS was (in mM): 120.5 NaCI, 4.8 KCl, 1.2 
MgSO,, 1.6 CaCl,, 1.2 NaH,PO,, 20.4 NaHCO,, 10.0 glucose and 1 .O 
pyruvate. The solution was continuously bubbled with 95% 02/5% 
CO, resulting in pH 7.6 at room temperature. 
The relaxing solution included (in mM): 90 potassium methanesul- 
fonate; 5 magnesium methanesulfonate; 20 PIPES; 4 ATP; 4 EGTA 
(pH 6.8, ionic strength 0.17). 
B-escin and GTPyS were obtained from Sigma, ionomycin from 
Calbiochem, and leupeptin from Vega Biotechnologies Inc. All chem- 
icals used for experiments were analytical grade. 
2.5. Statistical analyses 
Statistical analyses were performed by independent t-test for force 
development, myosin light chain phosphorylation and myosin light 
chain kinase activity ratio with experimental responses compared to 
control values. Two-tailed values were used with P values < 0.05 
considered significant. Data are expressed as mean + S.E.M. 
3. RESULTS 
Fig. 1 shows that the Ca2+ dependence of force devel- 
opment in tracheal smooth muscle made permeable 
with /%escin is similar to results reported for saponin- 
skinned tracheal smooth muscle [12]. Myosin light 
chain phosphorylation was also Ca2+-dependent with a 
maximal extent of phosphorylation (0.56 mol phos- 
phate/mol ight chain) observed at 3 and 10 PM Ca2+ 
(Fig. 1). Increases in the Ca2+ concentration also de- 
creased the activity ratio for myosin light chain kinase 
from 0.81 (resting value) to 0.40 at 10pM Ca2+ (Fig. 1). 
These data show that the Ca2+ dependence of the change 
in GaM, presumably due to phosphorylation at site A 
[5-71, is similar to the Ca2+-dependence of myosin light 
chain phosphorylation. These results are consistent with 
results obtained with smooth muscle cells in culture [7]. 
Previously, we observed that GTPyS did not evoke 
a contraction in relaxing solution containing 4 mM 
EGTA [ 121. Therefore, we selected a low Ca2’ concen- 
tration to optimize the effect of GTPyS on smooth mus- 
cle contraction. At 0.3 PM Ca” myosin light chain 
phosphorylation increased from 0.02 to 0.16 mol phos- 
phate/mol ight chain. This effect of Ca” was potenti- 
ated by 10 ,uM GTPyS where the extent of phosphoryl- 
ation increased to 0.29 mol phosphate/m01 light chain 
(Fig. 2). We also examined the effect of GTPyS on the 
myosin light chain kinase activity ratio. Increasing Ca2+ 
to 0.3 PM resulted in a decrease in myosin light chain 
kinase activity ratio from a control value of 0.81 to 0.68 
R 
Fig. 1. Ca2+-dependent properties of /I-escin permeable bovine tra- 
cheal smooth muscle. Smooth muscle strips were permeabilized by 
/3-escin in relaxing solution and incubated in different concentrations 
of Ca2’. Force responses were normalized to the amplitude of contrac- 
tion evoked by 10 PM Ca’+. Mean values represent U observations. 
Standard error bars smaller than symbol size are not shown. 
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Fig. 2. Effect of GTPyS and carbachol on myosin light chain kinase activity ratio and myosin light chain phosphorylation. Smooth muscle strips 
in relaxing solution were treated with 0.3 PM Ca2’, 0.3 PM Ca2’ plus 10 PM GTPyS or 0.3 PM Ca*’ plus 10 PM carbachol (CCh). Myosin light 
chain kinase activity ratio and myosin light chain phosphorylation were determined as described in Section 2. 
(Fig. 2). Addition of 10 PM GTPyS led to a further 
decrease in the activity ratio to 0.55 (Fig. 2). Addition 
of 10 ,uM carbachol to permeable smooth muscle cells 
in 0.3 ,uM Ca*+ also potentiated the myosin light chain 
and myosin light chain kinase phosphorylation re- 
sponses (Fig. 2). Myosin light chain phosphorylation 
increased from 0.16 to 0.35 mol phosphate/m01 light 
chain. Similarly, myosin light chain kinase activity ratio 
decreased from 0.67 to 0.50. 
4. DISCUSSION 
The decrease in myosin light chain kinase activity 
ratio with increasing Ca*’ concentrations in permeable 
smooth muscle is consistent with the Ca*‘-dependent 
phosphorylation of the enzyme [5-7,151. Most impor- 
tantly, the experiments with the permeable fibers show 
that Ca*+ alone is sufficient to affect the activity ratio 
supporting the hypothesis that Ca*‘/calmodulin-de- 
pendent protein kinase II phosphorylates myosin light 
chain kinase [7J This phosphorylation occurs at con- 
centrations of Ca*+ that also effect myosin light chain 
phosphorylation, indicating a similar responsiveness to 
physiological stimuli that increase cytosolic Ca*+ con- 
centrations. 
We also show that both GTPyS and carbachol en- 
hance the Ca*‘-dependent decrease in myosin light 
chain kinase activity ratio, as well as increasing myosin 
light chain phosphorylation in permeable smooth mus- 
cle. This result is consistent with the effect of carbachol 
in intact tracheal smooth muscle [6]. It has been shown 
previously that the decrease in the myosin light chain 
kinase activity ratio is related to the extent of site A 
phosphorylation [5,7]. Furthermore, it has been pro- 
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posed that the GTPyS-induced Ca*’ sensitization of 
myosin light chain phosphorylation is mediated by inhi- 
bition of a myosin light chain phosphatase, probably 
protein phosphatase- 1 [16-l 81. Since smooth muscle 
myosin light chain kinase is also dephosphorylated in 
vitro by protein phosphatase-1 [19], the possibility is 
raised that GTPyS acts to potentiate myosin light chain 
kinase and myosin light chain phosphorylation through 
inhibition of protein phosphatase-1 that dephospho- 
rylates both proteins. 
Potentiation of the phosphorylation of myosin light 
chain and myosin light chain kinase would have oppos- 
ing physiological effects. The Ca*’ sensitivity of myosin 
light chain phosphorylation is dependent upon the rela- 
tive activities of myosin light chain kinase and myosin 
light chain phosphatase. Because distinct G-protein-me- 
diated signal transduction pathways may exist for inhi- 
bition of light chain phosphatase via arachidonic acid 
[17] and phosphorylation of myosin light chain kinase 
by Ca*‘/calmodulin-dependent protein kinase II [6,7], 
the Ca*+ sensitivity of myosin light chain phosphoryla- 
tion may be subject to combined regulatory processes. 
Different pharmacological and physiological effecters 
could differentially modulate Ca*’ sensitivity due to 
specific actions on the two pathways [3,4]. 
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